Skip to main content
. 2020 Feb 14;9(2):e15969. doi: 10.2196/15969

Table 2.

Questionnaires to assess the primary outcome, secondary outcomes, moderators, mediators, and explanatory factors (including background attitudes, experiences of app use, and cost-effectiveness).

Variables Measurement (number of items) Measurement in weeks


0 (baseline) 4 8 12 24
Primary outcome measure

Fatigue symptoms FSIa (15): Severity Scale (4) and Interference Scale (7) IbCc IC IC IC IC
Secondary outcome measures

QoLd EORTC-QLQ-30e—Past week (1) and QoL—On Average (1) IC IC IC IC IC
Moderators

Demographic and health characteristics f IC
Mediators

Mindfulness MAAS-5g (5) IC IC IC IC IC

Physical activity (3) IC IC IC IC IC

Depression PROMIS-29h (4) IC IC IC IC IC

Sleep


Quality PROMIS-29 (1) IC IC IC IC IC


Disturbance SLC-90-Ri (3) IC IC IC IC IC

Fatigue catastrophizing FCSj (13): Rumination (4), Magnification (3), and Helplessness (6) IC IC IC IC IC
Explanatory factors

Patients expectancy (3) I C

Patients motivation (2) I C

Patients support in environment WHYMPI/MPIk (5) IC IC IC IC IC

Pain interference RAND-36l (2) IC IC IC IC IC

Experienced changes (5)
IC IC

User experience of the app (19) I C

Cost-effectiveness (6) IC

aFSI: Fatigue Symptom Inventory (fatigue severity scale, fatigue interference scale).

bI: intervention measurement.

cC: control measurement.

dQoL: quality of Life.

eEORTC-QLQ-30: European Organization for Research and Treatment for Cancer Quality of Life Questionnaire.

fNot applicable.

gMAAS-5: The Mindful Attention Awareness Scale.

hPROMIS-29: Patient-Reported Outcomes Measurement Information System (depression scale, sleep scale).

iSLC-90-R: Symptom Checklist-90-Revised (sleep disturbance scale).

jFCS: Fatigue Catastrophizing Scale (fatigue catastrophizing—adapted from PCS: Pain Catastrophizing Scale; rumination, magnification, and helplessness scales).

kWHYMPI/MPI: The West Haven-Yale Multidimensional Pain Inventory.

lRAND-36: Research and Development (pain interference scale).